Association Analysis of Driver Gene–Related Genetic Variants Identified Novel Lung Cancer Susceptibility Loci with 20,871 Lung Cancer Cases and 15,971 Controls
- 1 July 2020
- journal article
- research article
- Published by American Association for Cancer Research (AACR) in Cancer Epidemiology, Biomarkers & Prevention
- Vol. 29 (7), 1423-1429
- https://doi.org/10.1158/1055-9965.epi-19-1085
Abstract
Background: A substantial proportion of cancer driver genes (CDG) are also cancer predisposition genes. However, the associations between genetic variants in lung CDGs and the susceptibility to lung cancer have rarely been investigated. Methods: We selected expression-related single-nucleotide polymorphisms (eSNP) and nonsynonymous variants of lung CDGs, and tested their associations with lung cancer risk in two large-scale genome-wide association studies (20,871 cases and 15,971 controls of European descent). Conditional and joint association analysis was performed to identify independent risk variants. The associations of independent risk variants with somatic alterations in lung CDGs or recurrently altered pathways were investigated using data from The Cancer Genome Atlas (TCGA) project. Results: We identified seven independent SNPs in five lung CDGs that were consistently associated with lung cancer risk in discovery (P < 0.001) and validation (P < 0.05) stages. Among these loci, rs78062588 in TPM3 (1q21.3) was a new lung cancer susceptibility locus (OR = 0.86, P = 1.65 × 10−6). Subgroup analysis by histologic types further identified nine lung CDGs. Analysis of somatic alterations found that in lung adenocarcinomas, rs78062588[C] allele (TPM3 in 1q21.3) was associated with elevated somatic copy number of TPM3 (OR = 1.16, P = 0.02). In lung adenocarcinomas, rs1611182 (HLA-A in 6p22.1) was associated with truncation mutations of the transcriptional misregulation in cancer pathway (OR = 0.66, P = 1.76 × 10−3). Conclusions: Genetic variants can regulate functions of lung CDGs and influence lung cancer susceptibility. Impact: Our findings might help unravel biological mechanisms underlying lung cancer susceptibility.Funding Information
- National Natural Science of China (81820108028, 81521004)
- NIH (U19 CA148127, U19 CA203654)
- Cancer Prevention Research Institute of Texas (RR170048)
- National Natural Science of China (81922061)
- NIH (U01 CA209414)
- NIH (U01-CA063673, UM1-CA167462, U01-CA167462)
- Moffitt Cancer Center (P30 CA076292)
- SPORE in Lung Cancer (P50 CA119997)
This publication has 44 references indexed in Scilit:
- Comprehensive genomic characterization of squamous cell lung cancersNature, 2012
- SIFT web server: predicting effects of amino acid substitutions on proteinsNucleic Acids Research, 2012
- IRF6 is a mediator of Notch pro-differentiation and tumour suppressive function in keratinocytesThe EMBO Journal, 2011
- Developmental factor IRF6 exhibits tumor suppressor activity in squamous cell carcinomasProceedings of the National Academy of Sciences of the United States of America, 2011
- GCTA: A Tool for Genome-wide Complex Trait AnalysisAmerican Journal of Human Genetics, 2011
- ANNOVAR: functional annotation of genetic variants from high-throughput sequencing dataNucleic Acids Research, 2010
- GWAMA: software for genome-wide association meta-analysisBMC Bioinformatics, 2010
- A Genome-wide Association Study of Lung Cancer Identifies a Region of Chromosome 5p15 Associated with Risk for AdenocarcinomaAmerican Journal of Human Genetics, 2009
- Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profilesProceedings of the National Academy of Sciences of the United States of America, 2005
- A census of human cancer genesNature Reviews Cancer, 2004